Canine Flank Alopecia: A Narrative Review of Clinical Presentation, Genetic Basis, and Therapeutic Management.

Authors

Millie U M Y Verschuuren-Tjoeng, Yvette M Schlotter, Inge M van Geijlswijk, Ronette Gehring, Frank G van Steenbeek

Published in

Veterinary journal (London, England : 1997). Pages 106877. Sep 10, 2026. Epub Sep 10, 2026.

Abstract

Canine flank alopecia (CFA) is a seasonally recurrent skin disorder with a strong breed predisposition. Affected dogs display non-inflammatory, often hyperpigmented, well-circumscribed, symmetrical patches of hair loss, typically located on the thoracolumbar flanks. The onset of hair loss occurs during periods of decreasing daylight, usually in autumn or winter, with spontaneous partial or complete regrowth of hair during the following spring or summer. CFA is not associated with systemic symptoms and does not compromise the dog's general health. While the disorder is primarily considered a cosmetic condition, its chronic, cyclical nature and poorly understood pathogenesis present a challenge for veterinary clinicians and concerns for dog owners and breeders. This narrative review synthesizes current knowledge on CFA, discussing its clinical presentation, histopathological features, epidemiology, and suspected etiopathogenetic mechanisms, including photoperiod-dependent neuroendocrine influences and breed-related genetic predispositions. Diagnosis of CFA is based on signalment, the characteristic clinical presentation, exclusion of differential diagnoses, and supportive histopathology. Histological findings vary with disease stage and are suggestive, though not pathognomonic. Epidemiological data indicate breed predisposition and recurrence patterns, but quantitative data on prevalence are lacking. The pathogenesis appears multifactorial, likely involving interactions between environmental, neurohormonal, and genetic factors. Management of CFA ranges from watchful waiting to melatonin administration, with emerging treatments, such as low-level laser therapy, although evidence from placebo-controlled studies is limited. Current knowledge gaps on the genetic basis and biological pathomechanisms involved in CFA should be addressed through well-designed research, which will improve understanding and inform breeding strategies and management of CFA in veterinary practice.

PMID:
42722190
Bibliographic data and abstract were imported from PubMed on 11 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.